Both Eli Lilly $LLY (+0,49 %) and Novo Nordisk $NVO (+3,21 %) are disrupting the diet industry with their GLP-1 drugs, offering the potential for significant growth in the future.

$LLY (+0,49 %) is on track to become the first trillion dollar drug-maker...😯